Associations between HIFs and tumor immune checkpoints: mechanism and therapy
Abstract Hypoxia, which activates a variety of signaling pathways to enhance tumor cell growth and metabolism, is among the primary features of tumor cells. Hypoxia-inducible factors (HIFs) have a substantial impact on a variety of facets of tumor biology, such as epithelial-mesenchymal transition,...
Main Authors: | Jiayu Liu, Ying Jiang, Lingyan Chen, Zhiwen Qian, Yan Zhang |
---|---|
Format: | Article |
Language: | English |
Published: |
Springer
2024-01-01
|
Series: | Discover Oncology |
Subjects: | |
Online Access: | https://doi.org/10.1007/s12672-023-00836-7 |
Similar Items
-
Targeting Negative and Positive Immune Checkpoints with Monoclonal Antibodies in Therapy of Cancer
by: Katsiaryna Marhelava, et al.
Published: (2019-11-01) -
Current state of immune checkpoints therapy for glioblastoma
by: He Wang, et al.
Published: (2024-01-01) -
Modern cancer therapy: cryoablation meets immune checkpoint blockade
by: Qi Liu, et al.
Published: (2024-02-01) -
Review on combination strategy of immune checkpoint blockade, photodynamic therapy and nanomedicine against solid tumor
by: Xin Li, et al.
Published: (2021-11-01) -
Radiation and Immune Checkpoint Inhibitors: Combination Therapy for Treatment of Hepatocellular Carcinoma
by: Perla Chami, et al.
Published: (2023-11-01)